Bioliberty: Funding, Investors & Team (Oct 2026)
Bioliberty is a young healthcare technology company that focuses on creating innovative rehabilitation solutions for both degenerative and traumatic conditions.
Bioliberty has raised $11.6M across 4 funding rounds on record, the most recent a Series A of $8.3M announced in Mar 2026.
That round is in line with the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Bioliberty Company Profile and Key Stats
Latest funding round on record: Mar 2026.
Bioliberty Funding Rounds
Bioliberty raised $120k in a Grant announced in Aug 2022.
8 months later, a Seed of $2.7M was announced in Apr 2023.
8 months later, an undisclosed round of $440k was announced in Dec 2023.
2.3 years later, a Series A of $8.3M was announced in Mar 2026.
Bioliberty Founders and Leadership Team
No contact details are on record for this team yet.
Bioliberty Funding Compared to Other Biotechnology Startups
Bioliberty's latest round of $8.3M is in line with the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Bioliberty in Biotechnology and Edinburgh
Companies Similar to Bioliberty
R1 Therapeutics is a clinical‑stage biopharmaceutical company focused on discovering and developing new drug…
The perfect package for any general surgical trainee or resident. Progress from beginner to advanced surgical…
Argonaute RNA company research projects build on existing intellectual property.
An innovative C elegans company that serves the biotech, nutrition, and other industries and fields of study…
ViaNautis, previously known as SomaServe, was established in 2018 as a separate entity from UCL under the…
Alchemab is harnessing the naturally protective power of patient antibodies to keep people free of…
Biodexa Pharmaceuticals is an international specialty pharmaceutical company focused on oncology and other…
Concert Bio helps businesses create optimal microbial communities.
RQ Bio is a biotechnology company that develops long-acting monoclonal antibodies against seasonal influenza…
N4 Pharma is a drug reformulation company focused on developing and out licensing new versions of existing…
Laverock Therapeutics is working on developing a system for suppressing genes, which can be used to create…
Oak hill bio is a clinical-stage rare disease therapeutics company developing life-changing medicines.
Bioliberty Funding FAQs
What does Bioliberty do?
Bioliberty is a young healthcare technology company that focuses on creating innovative rehabilitation solutions for both degenerative and traumatic conditions.
How much funding has Bioliberty raised?
Bioliberty has raised $11.6M across 4 rounds on record. The most recent is a Series A of $8.3M announced in Mar 2026.
When did Bioliberty last raise funding?
Bioliberty's most recent funding round on record is a Series A of $8.3M, announced in Mar 2026.
Who founded Bioliberty?
FundedIQ lists Ross O'hanlon (Founder) at Bioliberty.
Who is the CEO of Bioliberty?
Rowan Armstrong is listed as CEO at Bioliberty.
Where is Bioliberty headquartered?
Bioliberty is based in Edinburgh, United Kingdom.
How many employees does Bioliberty have?
Bioliberty is in the 11-50 employee band.
How does Bioliberty's funding compare to other Biotechnology startups?
Bioliberty's latest round of $8.3M is in line with the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Bioliberty Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Bioliberty is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.